• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒感染后噬血细胞性淋巴组织细胞增生症病例。

Case of haemophagocytic lymphohistiocytosis following Epstein-Barr virus infection.

作者信息

Kraskovsky Valeri, Harhay Jason, Mador Martin Jeffery

机构信息

Pulmonary, Critical Care and Sleep Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA

Internal Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.

出版信息

BMJ Case Rep. 2021 Mar 31;14(3):e241222. doi: 10.1136/bcr-2020-241222.

DOI:10.1136/bcr-2020-241222
PMID:33789863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016084/
Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a rare diagnosis that carries a high degree of mortality. We present this case of a previously healthy 22-year-old woman, who was admitted acutely ill to the hospital. One week prior, she had been seen by her primary care physician for fatigue and malaise. At that time, she was noted to have anterior and posterior cervical lymphadenopathy. She was referred to the emergency room and was diagnosed with acute Epstein-Barr virus (EBV) mononucleosis based on her clinical symptoms and positive heterophile antibody test. She was discharged after an uneventful 48-hour stay on the wards. She represented 7 days after discharge with cough, fatigue, nausea, vomiting, epigastric abdominal pain, diarrhoea, weight loss and subjective fevers. She had also reported haematemesis, epistaxis and melaena. Vital signs included temperature 36.9°C, blood pressure 90/50 mm Hg, heart rate 130 beats per minute and respiratory rate 32 breaths per minute. Physical examination was notable for an acutely ill appearing woman with scleral icterus, hepatosplenomegaly and palpable cervical and axillary lymphadenopathy. Complete blood count showed pancytopaenia with haemoglobin 59 g/L (normal 120-160 g/L), white blood cell count 2.7×10/L (normal 4-10.5×10/L) and platelet count 50×10/L (normal 150-450×10/L). The white blood cell count differential included 58% neutrophils (normal 38%-77%) with immature neutrophils in band form elevated at 45% (normal <14%), 16% lymphocytes (normal 20%-48%), 7% monocytes (normal <12%) and no eosinophils (normal <6%). Blood smear revealed anisocytosis, poikilocytosis and hypochromia. Coagulation panel showed elevated levels of d-dimer level at 1.39 µg/mL (normal <0.45 µg/mL), prolonged prothrombin time at 34.4 s (normal 11-15 s), prolonged activated partial thromboplastin time of 55.6 s (normal 25-34 s), prolonged international normalised ratio at 3.31 (normal <1.1) and low fibrinogen 60 mg/dL (normal >200 mg/dL). Lipid panel showed cholesterol at 114 mg/dL (normal 125-200 mg/dL), triglycerides 207 mg/dL (normal 30-150 mg/dL), high-density lipoprotein cholesterol 10 mg/dL (normal 40-60 mg/dL) and low-density lipoprotein cholesterol 63 mg/dL (normal <100 mg/dL). Other lab abnormalities included elevated ferritin of 6513 ng/mL (normal 10-150 ng/mL) and elevated lactate dehydrogenase of 1071 unit/L (normal 95-240 unit/L). Soluble interleukin-2 receptor alpha level was elevated at 60 727 units/mL (normal 223-710 units/mL). Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan showed abnormal tracer localisation within the paratracheal, hilar, pelvic, abdominal and subcarinal lymph nodes, along with FDG-PET positive hepatosplenomegaly. A bone marrow biopsy showed hypercellular marrow (95% cellularity) with trilineage haematopoiesis, haemophagocytic cells, polytypic plasmacytosis and T-cell lymphocytosis, along with positive latent membrane protein-1 immunohistochemical staining for EBV. EBV quantitative DNA PCR showed >1 million copies. These findings were consistent with a diagnosis of HLH secondary to EBV infection. Despite intense therapy with the HLH-94 protocol, the patient expired from her illness after a prolonged hospital course.

摘要

噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见的诊断,死亡率很高。我们报告了一名此前健康的22岁女性病例,她因重病急症入院。一周前,她因疲劳和不适就诊于初级保健医生。当时,发现她有颈部前后淋巴结肿大。她被转诊至急诊室,根据临床症状和嗜异性抗体试验阳性,被诊断为急性爱泼斯坦-巴尔病毒(EBV)单核细胞增多症。在病房平稳度过48小时后她出院了。出院7天后,她因咳嗽、疲劳、恶心、呕吐、上腹部腹痛、腹泻、体重减轻和自觉发热前来就诊。她还报告有呕血、鼻出血和黑便。生命体征包括体温36.9°C、血压90/50 mmHg、心率130次/分钟和呼吸频率32次/分钟。体格检查发现一名急症面容的女性,有巩膜黄染、肝脾肿大以及可触及的颈部和腋窝淋巴结肿大。全血细胞计数显示全血细胞减少,血红蛋白59 g/L(正常120 - 160 g/L),白细胞计数2.7×10⁹/L(正常4 - 10.5×10⁹/L),血小板计数50×10⁹/L(正常150 - 450×10⁹/L)。白细胞分类计数包括58%中性粒细胞(正常38% - 77%),其中杆状核未成熟中性粒细胞升高至45%(正常<14%),16%淋巴细胞(正常20% - 48%),7%单核细胞(正常<12%),无嗜酸性粒细胞(正常<6%)。血涂片显示红细胞大小不均、异形红细胞症和低色素性。凝血检查显示D - 二聚体水平升高至1.39 μg/mL(正常<0.45 μg/mL),凝血酶原时间延长至34.4秒(正常11 - 15秒),活化部分凝血活酶时间延长至55.6秒(正常25 - 34秒),国际标准化比值延长至3.31(正常<1.1),纤维蛋白原低至60 mg/dL(正常>200 mg/dL)。血脂检查显示胆固醇114 mg/dL(正常125 - 200 mg/dL),甘油三酯207 mg/dL(正常30 - 150 mg/dL),高密度脂蛋白胆固醇10 mg/dL(正常40 - 60 mg/dL),低密度脂蛋白胆固醇63 mg/dL(正常<100 mg/dL)。其他实验室异常包括铁蛋白升高至6513 ng/mL(正常10 - 150 ng/mL)和乳酸脱氢酶升高至1071单位/L(正常95 - 240单位/L)。可溶性白细胞介素 - 2受体α水平升高至60727单位/mL(正常223 - 710单位/mL)。氟脱氧葡萄糖 - 正电子发射断层扫描(FDG - PET)显示气管旁、肺门、盆腔、腹部和隆突下淋巴结内有异常示踪剂定位,以及FDG - PET阳性的肝脾肿大。骨髓活检显示骨髓细胞增多(细胞含量95%),有三系造血、噬血细胞、多型浆细胞增多和T细胞淋巴细胞增多,同时EBV潜伏膜蛋白 - 1免疫组化染色阳性。EBV定量DNA PCR显示>100万拷贝。这些发现符合EBV感染继发HLH的诊断。尽管采用HLH - 94方案进行了强化治疗,但患者在漫长的住院过程后因病死亡。

相似文献

1
Case of haemophagocytic lymphohistiocytosis following Epstein-Barr virus infection.爱泼斯坦-巴尔病毒感染后噬血细胞性淋巴组织细胞增生症病例。
BMJ Case Rep. 2021 Mar 31;14(3):e241222. doi: 10.1136/bcr-2020-241222.
2
Haemophagocytic lymphohistiocytosis that spontaneously resolved: a case of EBV.自发性缓解的噬血细胞性淋巴组织细胞增生症:一例 EBV 感染。
BMJ Case Rep. 2020 Nov 12;13(11):e235544. doi: 10.1136/bcr-2020-235544.
3
Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.妊娠合并慢性活动性 EBV 相关噬血细胞性淋巴组织细胞增生症:病例报告。
BMC Pregnancy Childbirth. 2021 Oct 7;21(1):681. doi: 10.1186/s12884-021-04150-4.
4
Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review.从淋巴瘤中鉴别由噬血细胞性淋巴组织细胞增生症引起的暴发性 EBV 感染:病例报告及文献复习。
Diagn Pathol. 2023 Feb 22;18(1):28. doi: 10.1186/s13000-023-01307-x.
5
Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.肾移植受者中的噬血细胞性淋巴组织细胞增生症:2例报告
Transplant Proc. 2020 Jun;52(5):1566-1569. doi: 10.1016/j.transproceed.2020.02.047. Epub 2020 May 8.
6
[A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in an elderly woman].[一位老年女性的爱泼斯坦-巴尔病毒相关噬血细胞性淋巴组织细胞增生症病例]
Nihon Ronen Igakkai Zasshi. 2019;56(4):525-531. doi: 10.3143/geriatrics.56.525.
7
Hemophagocytic Lymphohistiocytosis and Pancreatic Cancer: A Rare Association.噬血细胞性淋巴组织细胞增生症与胰腺癌:一种罕见的关联
J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):68-71. doi: 10.55729/2000-9666.1225. eCollection 2023.
8
Epstein-Barr virus induced haemophagocytic lymphohistiocytosis.爱泼斯坦-巴尔病毒所致噬血细胞性淋巴组织细胞增生症
BMJ Case Rep. 2021 May 5;14(5):e241348. doi: 10.1136/bcr-2020-241348.
9
Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A.皮下脂膜炎样T细胞淋巴瘤合并噬血细胞综合征经环孢素A成功治疗。
Skinmed. 2006 Jul-Aug;5(4):195-7. doi: 10.1111/j.1540-9740.2006.04689.x.
10
[Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].儿童Epstein-Barr病毒相关噬血细胞性淋巴组织细胞增生症的临床分析及随访研究
Zhonghua Er Ke Za Zhi. 2010 Feb;48(2):121-6.

引用本文的文献

1
Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study.载脂蛋白A-I用于治疗重症新型冠状病毒肺炎所致的高炎症状态:一项前瞻性病例研究。
Front Pharmacol. 2022 Sep 26;13:936659. doi: 10.3389/fphar.2022.936659. eCollection 2022.

本文引用的文献

1
Hemophagocytic lymphohistiocytosis in adults.成人噬血细胞性淋巴组织细胞增生症
Proc (Bayl Univ Med Cent). 2020 Apr 3;33(3):326-330. doi: 10.1080/08998280.2020.1740052. eCollection 2020 Jul.
2
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.噬血细胞性淋巴组织细胞增生症:发病机制、诊断和治疗的最新进展。
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101515. doi: 10.1016/j.berh.2020.101515. Epub 2020 May 7.
3
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).噬血细胞性淋巴组织细胞增生症诊断中的挑战:北美组织细胞增生症联盟(NACHO)的建议。
Pediatr Blood Cancer. 2019 Nov;66(11):e27929. doi: 10.1002/pbc.27929. Epub 2019 Jul 24.
4
Refractory macrophage activation syndrome in the setting of adult-onset Still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus.在成人斯蒂尔病背景下出现难治性巨噬细胞活化综合征,皮肤活检发现噬血细胞性淋巴组织细胞增生症,使用卡那单抗和他克莫司治疗。
J Cutan Pathol. 2019 Jul;46(7):528-531. doi: 10.1111/cup.13466. Epub 2019 Apr 23.
5
Adalimumab for treatment of hemophagocytic syndrome following unrelated bone marrow transplantation in a boy with Behcet's disease and secondary myelodysplastic syndrome.阿达木单抗治疗一名患有白塞病和继发性骨髓增生异常综合征男孩的非亲缘性骨髓移植后噬血细胞综合征。
Bone Marrow Transplant. 2018 Sep;53(9):1214-1217. doi: 10.1038/s41409-018-0180-y. Epub 2018 Apr 27.
6
Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.爱泼斯坦-巴尔病毒与噬血细胞性淋巴组织细胞增生症
Front Immunol. 2018 Jan 8;8:1902. doi: 10.3389/fimmu.2017.01902. eCollection 2017.
7
Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH.可溶性白细胞介素-2受体是成人噬血细胞性淋巴组织细胞增生症的一项敏感诊断检测。
Blood Adv. 2017 Dec 6;1(26):2529-2534. doi: 10.1182/bloodadvances.2017012310. eCollection 2017 Dec 12.
8
Similar but not the same: Differential diagnosis of HLH and sepsis.相似但不同:噬血细胞性淋巴组织细胞增生症与脓毒症的鉴别诊断
Crit Rev Oncol Hematol. 2017 Jun;114:1-12. doi: 10.1016/j.critrevonc.2017.03.023. Epub 2017 Mar 23.
9
Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.噬血细胞综合征(HPSs),包括成人噬血细胞性淋巴组织细胞增生症(HLH):一项系统性综述。
Blood Rev. 2016 Nov;30(6):411-420. doi: 10.1016/j.blre.2016.05.001. Epub 2016 May 20.
10
Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years.成人噬血细胞性淋巴组织细胞增生症:一项历时7年的多中心病例系列研究
Br J Haematol. 2016 Feb;172(3):412-9. doi: 10.1111/bjh.13837. Epub 2015 Nov 5.